메타바이오메드

059210KOSDAQ

67.3 / 100

Reference Date: 2026-09-08

Financial Score32.0 / 40

News Sentiment21.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Slightly down 3.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MetaBioMed is a company specializing in the production and sale of medical devices and materials, including dental supplies, absorbable synthetic sutures, and cosmetic materials. The company focuses on dental nerve treatment materials and synthetic sutures, with growing demand for synthetic sutures replacing traditional animal-based products and sustained growth in the dental materials market.

Number of Employees

345people

Average Salary

52.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

8.76Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

0.83Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

9.75Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

1.68Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲11.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲42.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 16.9% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
메타바이오메드, 의료·화장품 신사업 호조…연내 소재혁신센터 가동
메타바이오메드의 신규 의료기기 및 화장품 사업이 성장을 견인하며 외형과 수익성 모두 향상될 것으로 기대된다.

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 3,835Won52-week high 6,52052-week low 3,490

1-month return2.0Point

1m -3.16% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25
Neutral반기보고서 (2026.06)2026-08-14